SK Biopharmaceuticals Co. has signed an MOU with Seoul Bio Hub to jointly operate an open innovation program, aiming to strengthen R&D capabilities and support domestic biotech startups through consulting and subsidized rent.
#YonhapInfomax #SKBiopharmaceuticals #SeoulBioHub #OpenInnovation #BiotechStartups #RDCapabilities #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=90587
SK Biopharmaceuticals Strengthens Pharmaceutical and Biotech R&D Capabilities—Signs MOU with Seoul Bio Hub
SK Biopharmaceuticals Co. has signed an MOU with Seoul Bio Hub to jointly operate an open innovation program, aiming to strengthen R&D capabilities and support domestic biotech startups through consulting and subsidized rent.
Yonhap Infomax
SK Group Appoints New Executives—Major Promotion of Next-Generation Leaders
SK Group has overhauled its executive lineup, promoting next-generation leaders with strong field and R&D backgrounds to drive business transformation and future growth.
Yonhap Infomax
Hite Jinro Opens New Integrated Research Institute, Vows to 'Continue Innovation on 100-Year History'
Hite Jinro unveils new integrated research institute, aiming to boost R&D capabilities and expand into new business areas while building on its century-long legacy
Yonhap Infomax
Acting President Choi - 'Removing Barriers Between Universities and Government Research Institutes, Establishing Over 3 New Joint Research Centers'
South Korea aims to establish joint research centers and train 40,000 space specialists by 2045, breaking down barriers between universities and government research institutes to boost R&D capabilities.
Yonhap Infomax